Priebe Waldemar 13D and 13G filings for CNS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-01 5:07 pm Purchase |
2019-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP |
Priebe Waldemar | 3 0.300% |
3 (New Position) |
Filing |